Martingale Asset Management L P Has $24.29 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Martingale Asset Management L P raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 247.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 59,758 shares of the company’s stock after purchasing an additional 42,577 shares during the quarter. Martingale Asset Management L P’s holdings in HCA Healthcare were worth $24,287,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. boosted its holdings in HCA Healthcare by 0.9% during the third quarter. Hantz Financial Services Inc. now owns 15,419 shares of the company’s stock valued at $6,267,000 after purchasing an additional 139 shares in the last quarter. Vinva Investment Management Ltd boosted its holdings in HCA Healthcare by 15.9% during the third quarter. Vinva Investment Management Ltd now owns 9,457 shares of the company’s stock valued at $3,814,000 after purchasing an additional 1,298 shares in the last quarter. Financial Counselors Inc. raised its stake in shares of HCA Healthcare by 3.0% in the third quarter. Financial Counselors Inc. now owns 1,551 shares of the company’s stock valued at $630,000 after acquiring an additional 45 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of HCA Healthcare by 2.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after acquiring an additional 41,190 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of HCA Healthcare by 19.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 91,571 shares of the company’s stock valued at $37,217,000 after acquiring an additional 15,071 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $325.47 on Friday. The firm has a market cap of $82.44 billion, a PE ratio of 14.61, a PEG ratio of 1.25 and a beta of 1.68. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1-year low of $245.84 and a 1-year high of $417.14. The company has a fifty day moving average price of $373.42 and a 200 day moving average price of $358.28.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is presently 11.85%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Barclays cut their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. KeyCorp dropped their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Oppenheimer boosted their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $380.29.

Insider Buying and Selling

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,155 shares of company stock valued at $5,608,990. Company insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.